Neoplasms, Endometrial Completed Phase 2 Trials for Temsirolimus (DB06287)

Also known as: Endometrial Neoplasm / Endometrial Neoplasms / Endometrial neoplasia / Endometrial neoplasm NOS / Neoplasm endometrium / Neoplasm of endometrium

IndicationStatusPhase
DBCOND0034079 (Neoplasms, Endometrial)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01460979Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial CarcinomaTreatment